{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:34:26Z","timestamp":1765784066778,"version":"3.48.0"},"reference-count":67,"publisher":"Informa UK Limited","issue":"14","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2025,12,6]]},"DOI":"10.1080\/10428194.2025.2560083","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:17:39Z","timestamp":1760527059000},"page":"2601-2610","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["The emerging role of tafasitamab in follicular lymphoma"],"prefix":"10.1080","volume":"66","author":[{"given":"Tanja","family":"Lazic","sequence":"first","affiliation":[{"name":"Hematology Unit, Azienda Unit\u00e0 Sanitaria Locale-IRCCS","place":["Reggio Emilia, Italy"]},{"name":"Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia","place":["Modena, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliano","family":"Barbieri","sequence":"additional","affiliation":[{"name":"Hematology Unit, Azienda Unit\u00e0 Sanitaria Locale-IRCCS","place":["Reggio Emilia, Italy"]},{"name":"Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia","place":["Modena, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8446-2285","authenticated-orcid":false,"given":"Stefano","family":"Luminari","sequence":"additional","affiliation":[{"name":"Hematology Unit, Azienda Unit\u00e0 Sanitaria Locale-IRCCS","place":["Reggio Emilia, Italy"]},{"name":"Chimomo Department, University of Modena and Reggio Emilia","place":["Reggio Emilia, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280218"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.008"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15708"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7534"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010263"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-621375"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.3990"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30090-5"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003805"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30225-4"},{"key":"e_1_3_3_13_1","unstructured":"U.S. Food and Drug Administration. FDA approves tafasitamab-cxix for relapsed or refractory follicular lymphoma. [Internet]; 2025. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-tafasitamab-cxix-relapsed-or-refractory-follicular-lymphoma."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-212970"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)14110-4"},{"key":"e_1_3_3_16_1","unstructured":"NCCN guidelines. Classic Follicular Lymphoma NCCN clinical practice guidelines in oncology \u2013 B-Cell Lymphomas. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf."},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.04.020"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-531327"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614598"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.0866"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.1652"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62175-7"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01073"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2024.2447371"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805104"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00843"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30097-3"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.3656"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.03.022"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.12.771"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.7163"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00010"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-217687"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15797"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-158631"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00335-7"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2239"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00166-2"},{"key":"e_1_3_3_40_1","unstructured":"European Medicines Agency. Breyanzi. Amsterdam: European Medicines Agency; 2023. Report No.: H-C-4731-II-0005. https:\/\/www.ema.europa.eu\/en\/documents\/variation-report\/breyanzi-h-c-4731-ii-0005-epar-assessment-report-variation_en.pdf."},{"key":"e_1_3_3_41_1","unstructured":"European Medicines Agency. Kymriah. European Medicines Agency; n.d. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/kymriah-epar-product-information_en.pdf."},{"key":"e_1_3_3_42_1","unstructured":"European Medicines Agency. Yescarta. Amsterdam: European Medicines Agency; 2018. https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/yescarta-epar-public-assessment-report_en.pdf"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00591-X"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021243"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01622-0"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02986-9"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00775"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30441-1"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281421"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.11.5921"},{"key":"e_1_3_3_51_1","unstructured":"European Medicines Agency. Minjuvi (tafasitamab) [Summary of Product Characteristics]. 2024. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/minjuvi-epar-product-information_en.pdf."},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2268"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03833-x"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.6.2098"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0711"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2019.08.003"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206939"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1403"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041869"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e32833d5938"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4405"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-625004"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1220558"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy056"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-124297"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283480"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021274"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-163160"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2025.2560083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:30:29Z","timestamp":1765783829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2025.2560083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":67,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,12,6]]}},"alternative-id":["10.1080\/10428194.2025.2560083"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2025.2560083","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"type":"print","value":"1042-8194"},{"type":"electronic","value":"1029-2403"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}